145 related articles for article (PubMed ID: 24696724)
1. VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
Huang C; Yuan X; Li Z; Tian Z; Zhan X; Zhang J; Li X
Int J Clin Exp Pathol; 2014; 7(3):1077-84. PubMed ID: 24696724
[TBL] [Abstract][Full Text] [Related]
2. VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
Huang C; Yuan X; Wan Y; Liu F; Chen X; Zhan X; Li X
Int J Clin Exp Pathol; 2014; 7(3):1022-31. PubMed ID: 24696719
[TBL] [Abstract][Full Text] [Related]
3. In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma.
Li Q; Wang AY; Xu QG; Liu DY; Xu PX; Yu D
Int J Clin Exp Pathol; 2015; 8(10):12234-42. PubMed ID: 26722408
[TBL] [Abstract][Full Text] [Related]
4. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.
Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ
Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228
[TBL] [Abstract][Full Text] [Related]
5. VE-statin/egfl7 expression in endothelial cells is regulated by a distal enhancer and a proximal promoter under the direct control of Erg and GATA-2.
Le Bras A; Samson C; Trentini M; Caetano B; Lelievre E; Mattot V; Beermann F; Soncin F
PLoS One; 2010 Aug; 5(8):e12156. PubMed ID: 20808444
[TBL] [Abstract][Full Text] [Related]
6. VE-statin/egfl7 regulates vascular elastogenesis by interacting with lysyl oxidases.
Lelièvre E; Hinek A; Lupu F; Buquet C; Soncin F; Mattot V
EMBO J; 2008 Jun; 27(12):1658-70. PubMed ID: 18497746
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of EGFL7 in malignant glioma.
Huang CH; Li XJ; Zhou YZ; Luo Y; Li C; Yuan XR
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1737-43. PubMed ID: 20213100
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis.
Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M
Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167
[TBL] [Abstract][Full Text] [Related]
9. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
[TBL] [Abstract][Full Text] [Related]
10. Endothelial Cell Activation Is Regulated by Epidermal Growth Factor-like Domain 7 (Egfl7) during Inflammation.
Pinte S; Caetano B; Le Bras A; Havet C; Villain G; Dernayka R; Duez C; Mattot V; Soncin F
J Biol Chem; 2016 Nov; 291(46):24017-24028. PubMed ID: 27650497
[TBL] [Abstract][Full Text] [Related]
11. EGFL7 enhances surface expression of integrin α
Dudvarski Stanković N; Bicker F; Keller S; Jones DT; Harter PN; Kienzle A; Gillmann C; Arnold P; Golebiewska A; Keunen O; Giese A; von Deimling A; Bäuerle T; Niclou SP; Mittelbronn M; Ye W; Pfister SM; Schmidt MHH
EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30065025
[TBL] [Abstract][Full Text] [Related]
12. EGFL7 regulates sprouting angiogenesis and endothelial integrity in a human blood vessel model.
Usuba R; Pauty J; Soncin F; Matsunaga YT
Biomaterials; 2019 Mar; 197():305-316. PubMed ID: 30684886
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of EGFL7 regulating neovascularization in diabetic retinopathy through the PI3K/AKT/VEGFA pathway.
Xian Y; Wang X; Yu Y; Chen X
Life Sci; 2024 Mar; 340():122483. PubMed ID: 38307238
[TBL] [Abstract][Full Text] [Related]
14. Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7.
Nichol D; Shawber C; Fitch MJ; Bambino K; Sharma A; Kitajewski J; Stuhlmann H
Blood; 2010 Dec; 116(26):6133-43. PubMed ID: 20947685
[TBL] [Abstract][Full Text] [Related]
15. [Epidermal growth factor-like domain 7 promotes endothelial cell migration and angiogenesis by activating ERK signaling pathway].
Cao Y; Lyu Q
Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):270-3. PubMed ID: 25975912
[TBL] [Abstract][Full Text] [Related]
16. miR‑24 regulates angiogenesis in gliomas.
Dai D; Huang W; Lu Q; Chen H; Liu J; Hong B
Mol Med Rep; 2018 Jul; 18(1):358-368. PubMed ID: 29749450
[TBL] [Abstract][Full Text] [Related]
17. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
[TBL] [Abstract][Full Text] [Related]
18. Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.
Delfortrie S; Pinte S; Mattot V; Samson C; Villain G; Caetano B; Lauridant-Philippin G; Baranzelli MC; Bonneterre J; Trottein F; Faveeuw C; Soncin F
Cancer Res; 2011 Dec; 71(23):7176-86. PubMed ID: 22037871
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts.
Liakouli V; Cipriani P; Di Benedetto P; Panzera N; Ruscitti P; Pantano I; Berardicurti O; Carubbi F; Esteves F; Mavria G; Del Galdo F; Giacomelli R
Sci Rep; 2019 Mar; 9(1):4589. PubMed ID: 30872612
[TBL] [Abstract][Full Text] [Related]
20. Egfl7 Represses the Vasculogenic Potential of Human Endothelial Progenitor Cells.
d'Audigier C; Susen S; Blandinieres A; Mattot V; Saubamea B; Rossi E; Nevo N; Lecourt S; Guerin CL; Dizier B; Gendron N; Caetano B; Gaussem P; Soncin F; Smadja DM
Stem Cell Rev Rep; 2018 Feb; 14(1):82-91. PubMed ID: 28980146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
